Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.

The drug industry offered its first significant sign of pushback against the Trump administration late Tuesday, after a day of dramatic cuts to U.S. public health infrastructure. Drug stocks tumbled ...

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

As the storyline unfolds with Lily's increasing reliance on drugs, concerned EastEnders watchers are growing fearful for her ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Pfizer in 2019 sold $20 billion of drugs in the U.S. Its federal tax bill? Zero. That revelation was part of a Senate Finance ...

EastEnders viewers have been left 'fearing' Lily Slater (Lillia Turner) is about to lose her younger daughter Charli in a ...

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. Viking doesn't sell weight ...

Smoking already seemed to be making a comeback in pop culture. With the mass HHS layoffs, will tobacco's grip on young people grow tighter?

After Hims & Hers (HIMS) announced yesterday that the company is broadening its weight loss offering to include Lilly’s (LLY) branded ...